Company: ABLV
Filing Date: 2025-04-23
Form Type: 20-F
Source: 0001213900-25-034677
Chunk: 122

Company: Able View Global Inc.
Filing Date: 2025-04-23
Form: 20-F
Item: Item 4A
Chunk 122
---
────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (d)      For the year ended December 31, 2023, we extended                                                                                             
           loans of aggregating $1.2 million to two third parties to support their working capital. The loans were interest-free and repayable on        
           demand. During the year ended December 31, 2023, one of the third parties fully repaid loans of $0.7 million.                                 
                                                                                                                                                         
                                                                                                                                                         
                                                                                                                                                         
           During the year ended December 31, 2024, we did                                                                                               
           not make loans to or collected loans from third parties, and the movement in the balance was due to change in exchange rates. As the Company  
           had outstanding balances due to two third parties, the Company expected to settle the outstanding balance within 12 months.                   
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (e)      As of December 31, 2023, we had compensation receivable due from one supplier. The compensation receivable arose from quality issues of cosmetic products, and the supplier agreed to make cash c...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Inventories

The balance of inventories was $6.6 million and
17.4 million as of December 31, 2024 and 2023, respectively. The decrease in inventory balance was due to the fact that (i) we lowered
our stocks of inventories as of December 31, 2024, which was in line with the decrease in revenues, and (ii) we provided inventory write-down
of $4.9 million against cosmetics products due to slow moving.

Short-term loans

As of December 31, 2024 and 2023, the balance
of short-term borrowings primarily consisted of the following items:

  Short-term loans from financial institutions other than banks      $                         -      $671,355      
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                                                     December 31,                     December 31,  
  Short-term loans from banks                                                          7,972,764      2,213,164     
                                                                     $                 7,972,764      $2,884,519    

  (a)      During